Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

U.S. lawmakers have requested information from Pfizer concerning claims by former executive Philip Dormitzer that the company ...

In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political threats. The big story: Trump’s tariff regime is open to compromises.

For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying ...

US House Panel Seeks Information From Pfizer Over Alleged COVID Vaccine Delay By Ahmed Aboulenein and Michael Erman WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for ...

Ruling expected to have far-reaching implications for transparency, accountability in EU institutions - Anadolu Ajansı ...

European Commission president exchanged messages with US pharmaceutical CEO during negotiations for Covid vaccines ...

WASHINGTON, May 15 (Reuters) - U.S. lawmakers on Thursday asked Pfizer Inc (PFE.N), opens new tab for information on alleged comments by a former executive suggesting its research executives ...